1. Home
  2. LFST vs DAWN Comparison

LFST vs DAWN Comparison

Compare LFST & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeStance Health Group Inc.

LFST

LifeStance Health Group Inc.

HOLD

Current Price

$6.34

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.42

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFST
DAWN
Founded
2015
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LFST
DAWN
Price
$6.34
$21.42
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
$9.71
$26.00
AVG Volume (30 Days)
2.5M
6.4M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,424,285,000.00
$158,182,000.00
Revenue This Year
$17.18
$55.03
Revenue Next Year
$14.02
$28.12
P/E Ratio
N/A
N/A
Revenue Growth
13.85
20.60
52 Week Low
$3.74
$5.64
52 Week High
$8.09
$21.46

Technical Indicators

Market Signals
Indicator
LFST
DAWN
Relative Strength Index (RSI) 38.80 81.44
Support Level $6.16 $10.30
Resistance Level $6.63 N/A
Average True Range (ATR) 0.21 0.07
MACD -0.00 -0.16
Stochastic Oscillator 12.34 79.55

Price Performance

Historical Comparison
LFST
DAWN

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: